Phase is a manufacturing hardware company specializing in 3D-printed medical devices for microfluidics. Utilizing a proprietary platform, Phase enables the 3D printing of PDMS (Sylgard 184) and other biocompatible materials at a commercial scale and previously unattainable resolution. Their innovative technology supports the creation of microfluidics with integrated components such as valves, sensors, and electrodes, propelling advancements in the biotech industry.
Phase has made significant strides in the field of bioinnovation by offering industry-standard materials and high-resolution printing capabilities. Their impact is evident in the enhanced speed and precision of microfluidic device production, which is crucial for various medical and research applications. By pushing the boundaries of what is possible with 3D printing in microfluidics, Phase continues to drive forward the capabilities and applications of biotechnology.
